Fibronectin confers survival against chemotherapeutic agents but not against radiotherapy in DU145 prostate cancer cells: involvement of the insulin like growth factor-1 receptor

The Prostate
Francis ThomasClaire M Perks

Abstract

Tumor growth is influenced by an increase in cell proliferation and a reduction in apoptosis; both of which are affected by alterations in extracellular matrix (ECM). Our aim was to assess if the susceptibility of prostate cancer cells to apoptosis induced by either chemotherapeutics or radiotherapy was altered by changes in the ECM. Prostate cancer cell lines LNCaP and DU145 (androgen independent) cells were treated with chemotherapeutics (ceramide and docetaxel) or radiotherapy in the presence or absence of fibronectin, laminin, or vitronectin. Cell death was assessed using Trypan blue cell counting and apoptosis was confirmed by measuring PARP cleavage by Western immunoblotting (WIB). To identify a mechanism of action, changes in the abundance (WIB) or association (immunoprecipitation followed by WIB) of key proteins was also assessed. We found that fibronectin, but not laminin or vitronectin activated a survival pathway that protected DU145 but not LNCaP prostate cancer cells against ceramide and docetaxel-induced apoptosis but not that induced by radiotherapy. This survival effect involved the insulin-like growth factor (IGF-I) and beta1 integrin receptors and was associated with an increase in the recruitment of the beta1...Continue Reading

References

Jan 1, 1993·Journal of Cancer Research and Clinical Oncology·C M WitkowskiA E Cress
Aug 1, 1994·Current Opinion in Pediatrics·P Cohen, R G Rosenfeld
Feb 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S J MurantN J Maitland
Jan 27, 1998·The Journal of Biological Chemistry·J Liliental, D D Chang
Jul 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T AiharaS Imaoka
Jun 30, 2000·Biochemical and Biophysical Research Communications·F Kim, M A Corson
Nov 7, 2001·The Journal of Urology·J A TuxhornD R Rowley
Dec 21, 2002·Differentiation; Research in Biological Diversity·Shian-Ying Sung, Leland W K Chung
Feb 18, 2003·Molecular Biology of the Cell·Elisabeth A CoxAnna Huttenlocher
Jul 8, 2003·The Journal of Pathology·Fred T Bosman, Ivan Stamenkovic
Dec 23, 2003·Journal of Cellular Biochemistry·Ray B Nagle
Oct 8, 2004·The New England Journal of Medicine·Daniel P PetrylakE David Crawford
Nov 18, 2004·American Journal of Surgery·Krista A FrankenberryLinda C Vona-Davis
Feb 3, 2005·World Journal of Urology·Daniel P Petrylak
Jun 28, 2005·International Journal of Cancer. Journal International Du Cancer·Hanna E RauhalaTapio Visakorpi
Apr 29, 2006·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Haakon SkogsethJostein Halgunset
Jul 5, 2006·Urologic Oncology·David S Meinbach, Bal L Lokeshwar
Dec 19, 2006·Molecular Cancer Therapeutics·Kathy MulgrewDavid A Tice
Apr 9, 2008·Current Medicinal Chemistry·R Schmidmaier, P Baumann
Jul 22, 2008·Der Urologe. Ausg. A·U Ganswindt, C Belka
Jul 24, 2008·Nature Clinical Practice. Oncology·Brian Schurko, William K Oh
Oct 8, 2008·American Journal of Clinical Oncology·William M MendenhallNancy P Mendenhall
Oct 29, 2008·Langmuir : the ACS Journal of Surfaces and Colloids·Döne DemirgözEfrosini Kokkoli
Nov 18, 2008·The Lancet Oncology·Manit AryaMark Emberton

❮ Previous
Next ❯

Citations

Nov 28, 2012·European Journal of Nuclear Medicine and Molecular Imaging·Anna OrlovaTorbjörn Gräslund
May 9, 2012·Chemotherapy Research and Practice·Fawzi Aoudjit, Kristiina Vuori
May 29, 2013·Pharmacology & Therapeutics·Yasuhito OnoderaHisataka Sabe
Oct 7, 2014·Mutation Research. Fundamental and Molecular Mechanisms of Mutagenesis·Gagan DeepRajesh Agarwal
Jun 3, 2014·Biology·Carrie J LovittVicky M Avery
Apr 12, 2016·Pharmacology & Therapeutics·Sritama Nath, Gayathri R Devi
Jun 28, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Iris Eke, Nils Cordes
Dec 25, 2012·Biochemical and Biophysical Research Communications·Andrei MorozSérgio L Felisbino
Oct 19, 2016·Endocrine-related Cancer·K M BiernackaC M Perks
Apr 13, 2019·Journal of Cellular Biochemistry·Yuzhen ZhouYan Huang
Jul 11, 2014·Anti-cancer Drugs·Cui-Cui SunZu-Hua Gao
May 27, 2016·Hormone Molecular Biology and Clinical Investigation·Changhu LeeJiyoung Park
Jan 13, 2018·Journal of Bioenergetics and Biomembranes·Andréia Vasconcelos-Dos-SantosWagner B Dias
Dec 10, 2020·Pharmaceutics·Bárbara PintoHassan Bousbaa
Jul 8, 2019·Molecular Biology Reports·Munmun Panda, Bijesh K Biswal
Dec 17, 2011·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Vladimir TolmachevAnna Orlova
Sep 8, 2010·Nature Reviews. Urology·Maria KarlouEleni Efstathiou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.